Literature DB >> 14567644

The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

L Illum1, M Hinchcliffe, S S Davis.   

Abstract

PURPOSE: Investigate the effect of blood sampling site and physicochemical characteristics of drugs on the pharmacokinetic (PK) parameters obtained after intravenous and nasal administration in sheep and compare results with computer simulations.
METHODS: Three drugs, insulin, morphine, and nicotine, were administered nasally and by intravenous (IV) injection to sheep, and serial blood samples collected concurrently from the carotid artery (insulin, morphine) or cephalic vein (nicotine) and jugular vein. Plasma drug concentrations were measured, and pharmacokinetic and statistical analyses performed, to evaluate sampling site differences.
RESULTS: After nasal insulin, bioavailabilities calculated from the two blood sampling site data were comparable. In contrast, apparent bioavailabilities following nasal morphine or nicotine were significantly higher when sampling was from the jugular vein. These results were supported by computer simulations. These observations are attributed to the greater effects of noninstantaneous mixing of drugs for jugular vein sampling following nasal dosing, compared to the other sampling sites, which is significant for drugs that are rapidly and well absorbed and that have a high volume of distribution (Vd).
CONCLUSION: The results clearly show that the characteristics of the drug and the blood sampling site can have a significant effect on the pharmacokinetic results obtained after nasal administration in sheep.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567644     DOI: 10.1023/a:1025722614154

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  Nasal drug delivery--possibilities, problems and solutions.

Authors:  Lisbeth Illum
Journal:  J Control Release       Date:  2003-02-21       Impact factor: 9.776

2.  Interspecies differences in the nasal absorption of insulin.

Authors:  F W Merkus; J C Verhoef; S G Romeijn; N G Schipper
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

3.  Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.

Authors:  W A Lee; B A Narog; T W Patapoff; Y J Wang
Journal:  J Pharm Sci       Date:  1991-08       Impact factor: 3.534

4.  Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.

Authors:  L Illum; S S Davis; M Pawula; A N Fisher; D A Barrett; N F Farraj; P N Shaw
Journal:  Biopharm Drug Dispos       Date:  1996-11       Impact factor: 1.627

5.  Intranasal delivery of morphine.

Authors:  L Illum; P Watts; A N Fisher; M Hinchcliffe; H Norbury; I Jabbal-Gill; R Nankervis; S S Davis
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

6.  Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.

Authors:  J P Longenecker; A C Moses; J S Flier; R D Silver; M C Carey; E J Dubovi
Journal:  J Pharm Sci       Date:  1987-05       Impact factor: 3.534

7.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates.

Authors:  S H Steiner; M J Moor; M H Bickel
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

8.  Intranasal absorption of buprenorphine--in vivo bioavailability study in sheep.

Authors:  K Lindhardt; C Ravn; S Gizurarson; E Bechgaard
Journal:  Int J Pharm       Date:  2000-09-15       Impact factor: 5.875

9.  Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.

Authors:  Yu Hui Cheng; P Watts; M Hinchcliffe; R Hotchkiss; R Nankervis; N F Faraj; A Smith; S S Davis; L Illum
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

10.  Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Authors:  A M Dyer; M Hinchcliffe; P Watts; J Castile; I Jabbal-Gill; R Nankervis; A Smith; L Illum
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.